Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 361621 - 361640 out of 489036 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Romania (legislatie) | (L01FD01) trastuzumab | HERCEPTIN 600mg/5ml | Cutie cu un flacon de 6 ml din sticla transparenta cu dop continand 5ml solutie (600 mg trastuzumab),SOL. INJ., 600mg/5ml | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | ROCHEREGISTRATIONGMBH |
| Romania (legislatie) | (L01FD01) trastuzumab | HERCEPTIN 150mg | Cutie x 1 flac. pulb. pt. conc. pt. sol. perf. continând 150 mg trastuzumab,PULB. PT. CONC. PT. SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | ROCHEREGISTRATIONGMBH |
| Romania (legislatie) | (L01FD01) trastuzumab | HERZUMA 150 mg | Cutie cu 1 flac. cu capacitatea de 20 ml din sticla transparenta continand 150 mg trastuzumab,PULB. PT. CONC. PT. SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT. |
| Romania (legislatie) | (L01FD01) trastuzumab | KANJINTI 150 mg | Cutie cu 1 flac. cu capacitatea de 20 ml din sticla transparenta ce conține 150 mgtrastuzumab,PULB. PT.CONC. PT. SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AMGENEUROPEB.V. |
| Romania (legislatie) | (L01FD01) trastuzumab | OGIVRI 150 mg | Cutie x 1 flac. cu capacitatea de 15 ml din sticla transparenta de tip I cu dop din cauciuc butilic laminat cu film de fluoro-rezina continand trastuzumab 150 mg (4 ani),PULB. PT. CONC. PT. SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | MYLANS.A.S. |
| Romania (legislatie) | (L01FD01) trastuzumab | OGIVRI 150 mg | Cutie x 1 flac. cu capacitatea de 15 ml din sticla transparenta de tip I cu dop din cauciuc butilic laminat cu film de fluoro-rezina continând trastuzumab 150 mg,PULB. PT. CONC. PT. SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | VIATRISLIMITED-IRLANDA |
| Romania (legislatie) | (L01FD01) trastuzumab | OGIVRI 150 mg | Cutie x 1 flac. cu capacitatea de 15 ml din sticla transparenta de tip I cu dop din cauciuc butilic laminat cu film de fluoro-rezina continând trastuzumab 150 mg (4 ani),PULB. PT. CONC. PT. SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BIOSIMILARCOLLABORATIONSIRELANDLIMITED-IRLANDA |
| Romania (legislatie) | (L01FD01) trastuzumab | TRAZIMERA 150 mg | Cutie cu 1 flac. cu capacitatea de 15 ml conținând 150 mg trastuzumab,PULB. PT. CONC. PT. SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PFIZEREUROPEMAEEIG |
| Romania (legislatie) | (L01FD01) trastuzumab | ZERCEPAC 150 mg | Cutie cu 1 flac. cu capacitatea de 20 ml din sticla cu dop din cauciuc bromobutilic x 150 mg pulb. pt. conc. pt. sol. perf.,PULB. PT. CONC. PT. SOL. PERF., 150mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U. |
| Romania (legislatie) | (L01FD01) trastuzumab | KANJINTI 420 mg | Cutie cu 1 flac. cu capacitatea de 50 ml din sticla transparenta ce conține 420 mgtrastuzumab,PULB. PT.CONC. PT. SOL. PERF., 420mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AMGENEUROPEB.V. |
| Romania (legislatie) | (L01FD01) trastuzumab | TRAZIMERA 420 mg | Cutie cu 1 flac. cu capacitatea de 30 ml conținând 420 mg trastuzumab,PULB. PT. CONC. PT. SOL. PERF., 420mg | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PFIZEREUROPEMAEEIG |
| Romania (legislatie) | (L01FD01) trastuzumab | ZERCEPAC 420 mg | Cutie cu 1 flac. cu capacitatea de 50 ml din sticla cu dop din cauciuc bromobutilic x 420 mg pulb. pt. conc. pt. sol. perf.,PULB. PT. CONC. PT. SOL. PERF., 420mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U. |
| Romania (legislatie) | (L01FD01) trastuzumab | ZERCEPAC 60 mg | Cutie cu 1 flac. cu capacitatea de 10 ml din sticla cu dop din cauciuc bromobutilic x 60 mg pulb. pt. conc. pt. sol. perf.,PULB. PT. CONC. PT. SOL. PERF., 60mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U. |
| Romania (legislatie) | (L01FD02) pertuzumab | PERJETA 420mg | Cutie x 1 flacon din sticla x 14ml concentrat pentru solutie perfuzabila x 420mg pertuzumab,CONC. PT. SOL. PERF., 420mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH |
| Romania (legislatie) | (L01FD03) trastuzumab emtansine | KADCYLA 100mg | Cutie cu un flacon a 15ml x100 mg concentrat pentru soluție perf uzabila,PULB. PT. CONC. PT. SOL. PERF., 100mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH |
| Romania (legislatie) | (L01FD03) trastuzumab emtansine | KADCYLA 160mg | Cutie cu un flacon a 20ml xl60 mg concentrat pentru soluție perfuzabila,PULB. PT.CONC. PT. SOL. PERF., 160mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH |
| Romania (legislatie) | (L01FE01) cetuximab | ERBITUX 5mg/ml | Cutie x 1 flac. din sticla x 20 ml sol. perf.,SOL. PERF., 5mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Head and Neck Neoplasms;Colorectal Neoplasms | MERCKEUROPEB.V. |
| Romania (legislatie) | (L01FE02) panitumumab | VECTIBIX 20mg/ml | Cutie x 1 flac. x 400mg panitumumab x 20ml,CONC. PT. SOL. PERF., 20mg/ ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AMGENEUROPEB.V. |
| Romania (legislatie) | (L01FE02) panitumumab | VECTIBIX 20mg/ml | Cutie x 1 flac. x 100mg panitumumab x 5ml,CONC. PT. SOL. PERF., 20mg/ ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AMGENEUROPEB.V. |
| Romania (legislatie) | (L01FF01) nivolumab | OPDIVO 10 mg/ml | Cutie cu 1 flac. din sticlă de tip I x 40 mg conc. pt. sol. perf. (2 ani),CONC. PT. SOL. PERF., 10 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | BRISTOL-MYERSSQUIBBPHARMAEEIG-IRLANDA |
Pages
